U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H10O2
Molecular Weight 150.1745
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PAROXYPROPIONE

SMILES

CCC(=O)C1=CC=C(O)C=C1

InChI

InChIKey=RARSHUDCJQSEFJ-UHFFFAOYSA-N
InChI=1S/C9H10O2/c1-2-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3

HIDE SMILES / InChI

Molecular Formula C9H10O2
Molecular Weight 150.1745
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Paroxypropione (brand names Frenantol, Frenormon, Hypophenon, Paroxon, Possipione, Profenone is a synthetic, non-steroidal estrogen that has been used medically as an antigonadotropin in Spain and Italy. Paroxypropione was first synthesized in 1902. Its antigonadotropic properties were discovered in 1951 and it entered clinical use shortly thereafter. Paroxypropione is a product from the oxidative splitting of stilbestrol, with a low degree of estrogenicity, has been found a valuable drug for checking the growth of lung metastases secondary to certain malignant tumors such as chorionepitheliomas or nephrobiastomas. As the drug possesses relatively low affinity for the estrogen receptor and must be given at high dosages to achieve significant estrogenic and antigonadotropic action.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
150.56 µM [IC50]
176.0 µM [IC50]
293.0 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Frenantol
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Paroxypropione inhibits 17b-HSD3 with IC50 150.56 uM
Substance Class Chemical
Record UNII
X9952001TG
Record Status Validated (UNII)
Record Version